Multicenter open non-comparative clinical study to evaluate the efficacy and safety of three months Tavanic course (levofloxacin) in combine treatment of multi-drug-resistant tuberculosis (MDR-TB).

Trial Profile

Multicenter open non-comparative clinical study to evaluate the efficacy and safety of three months Tavanic course (levofloxacin) in combine treatment of multi-drug-resistant tuberculosis (MDR-TB).

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Mar 2012

At a glance

  • Drugs Levofloxacin (Primary) ; Antituberculars
  • Indications Pulmonary tuberculosis
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Sanofi
  • Most Recent Events

    • 03 Jun 2008 Status changed from recruiting to completed according to ClinicalTrials.gov
    • 07 Aug 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top